BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33243777)

  • 21. [A Retrospective Analysis of Systematic Lymphadenectomy for Loco-Regional(pT1)Epithelial Ovarian Cancer].
    Okubo R; Ito K; Nakatsuka S; Watanabe H; Yagi T; Odani C; Ono H; Shimoji K; Nakagawa M; Goto M; Tsuruta T; Hori K; Tashima L
    Gan To Kagaku Ryoho; 2017 Aug; 44(8):681-684. PubMed ID: 28860440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional variation in surgical assessment of lymph nodes for staging among women with early-stage epithelial ovarian cancer.
    Ulanday KT; Ward KK; Macera CA; Ji M; Plaxe SC
    Gynecol Oncol; 2014 Feb; 132(2):411-5. PubMed ID: 24246773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of lymph node staging in presumed early-stage ovarian carcinoma.
    Rodrigues Teixeira F; Vertematti de Castro V; Chaves Faloppa C; Mantoan H; Yuri Kumagai L; Narcizo Oliveira Menezes A; Badiglian-Filho L; De Brot L; Tirapelli Goncalves B; Paiva Gadelha Guimaraes A; Baiocchi G
    Eur J Obstet Gynecol Reprod Biol; 2022 Nov; 278():6-10. PubMed ID: 36108452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive factors of lymph node metastasis and pattern of repartition in patients with epithelial ovarian cancer.
    Atallah D; Arab W; Dagher B; Khalil N; El Rawadi E; Atallah B; Ghaname W; El Kassis N; Chahine G; Moubarak M
    Future Oncol; 2021 Dec; 17(36):5093-5101. PubMed ID: 34821515
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature.
    Desteli GA; Gultekin M; Usubutun A; Yuce K; Ayhan A
    World J Surg Oncol; 2010 Nov; 8():106. PubMed ID: 21114870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
    Song N; Gao Y
    Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic Lymphadenectomy.
    Heitz F; Harter P; Ataseven B; Heikaus S; Schneider S; Prader S; Bommert M; Fisseler-Eckhoff A; Traut A; du Bois A
    Ann Surg Oncol; 2018 Jul; 25(7):2053-2059. PubMed ID: 29633097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study.
    Deng T; Liu K; Chen L; Chen X; Li HW; Guo H; Zhang H; Xiang L; Feng X; Wang X; Ngan HY; Zhao J; Zou D; Liu Q; Liu J
    J Gynecol Oncol; 2023 May; 34(3):e52. PubMed ID: 37116952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.
    Bogani G; Tagliabue E; Ditto A; Signorelli M; Martinelli F; Casarin J; Chiappa V; Dondi G; Leone Roberti Maggiore U; Scaffa C; Borghi C; Montanelli L; Lorusso D; Raspagliesi F
    Gynecol Oncol; 2017 Oct; 147(1):61-65. PubMed ID: 28779965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
    Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
    Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for lymph node metastasis in ovarian cancer: Implications for systematic lymphadenectomy.
    Zhou J; Sun JY; Wu SG; Wang X; He ZY; Chen QH; Li FY
    Int J Surg; 2016 May; 29():123-7. PubMed ID: 27000718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of lymphadenectomy and intra-operative tumor rupture on survival in early-stage mucinous ovarian cancers.
    Kim SR; Madariaga A; Hogen L; Vicus D; Covens A; Parra-Herran C; Lheureux S; Gien LT
    Int J Gynecol Cancer; 2023 May; 33(5):755-760. PubMed ID: 36914170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.
    Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Tano S; Matsui S; Kajiyama H
    Jpn J Clin Oncol; 2021 Mar; 51(3):387-392. PubMed ID: 33253382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma.
    Nasioudis D; Chapman-Davis E; Witkin SS; Holcomb K
    Gynecol Oncol; 2017 Feb; 144(2):414-419. PubMed ID: 27908528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary.
    Mazina V; Devins K; Philp L; Bercow AS; James K; Bregar A; Sisodia RC; Oliva E; Del Carmen M
    Int J Gynecol Cancer; 2023 Sep; 33(9):1434-1439. PubMed ID: 37567599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.
    Takei Y; Takahashi S; Machida S; Taneichi A; Yoshiba T; Takahashi Y; Yoshida C; Saga Y; Matsubara S; Fujiwara H
    Int J Clin Oncol; 2018 Oct; 23(5):930-935. PubMed ID: 29679177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery?
    Benoit L; Zerbib J; Koual M; Nguyen-Xuan HT; Delanoy N; Le Frère-Belda MA; Bentivegna E; Bats AS; Fournier L; Azaïs H
    Gynecol Oncol; 2021 Sep; 162(3):667-673. PubMed ID: 34217542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphadenectomy in surgical stage I epithelial ovarian cancer.
    Svolgaard O; Lidegaard O; Nielsen ML; Nedergaard L; Mosgaard BJ; Lidang M; Mogensen O; Kock K; Blaakaer J; Staehr E; Andersen ES; Grove A; Høgdall C
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):256-60. PubMed ID: 24447203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
    Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
    Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel Lymph Node Technique in Apparent Early Ovarian Cancer: Laparoscopic Technique.
    Lago V; Bello P; Matute L; Padilla-Iserte P; Marina T; Agudelo M; Domingo S
    J Minim Invasive Gynecol; 2020; 27(5):1019-1020. PubMed ID: 31628986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.